Synthesis and cytotoxic activity of certain trisubstituted azetidin-2-one derivatives as a cis-restricted combretastatin A-4 analogues

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorElmeligie S.
dc.contributor.authorTaher A.T.
dc.contributor.authorKhalil N.A.
dc.contributor.authorEl-said A.H.
dc.contributor.otherPharmaceutical Organic Chemistry Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherCairo University
dc.contributor.otherCairo
dc.contributor.otherEgypt; Organic Chemistry Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherOctober University for Modern Sciences and Arts (MSA)
dc.contributor.other6th October City
dc.contributor.otherGiza
dc.contributor.otherEgypt; Pharmaceutical Organic Chemistry Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherMisr University for Science and Technology
dc.contributor.other6th October City
dc.contributor.otherGiza
dc.contributor.otherEgypt
dc.date.accessioned2020-01-09T20:41:28Z
dc.date.available2020-01-09T20:41:28Z
dc.date.issued2017
dc.descriptionScopus
dc.description.abstractNovel series of 1,3,4-trisubstituted azetidin-2-one derivatives 8a�p were synthesized and proposed as cytotoxic agents acting via inhibition of tubulin at the colchicine binding site. The design of the target compounds was based upon modification in the structure of the vascular targeting agent combretastatin A-4 (CA-4). The cis double bond linker in CA-4 was replaced with the azetidin-2-one ring aiming to prevent the cis/trans isomerization that suppresses the activity of CA-4, thereby enhancing its antiproliferative activity. All new compounds were investigated in vitro against MCF-7 and HCT-116 cell lines. The inhibition of tubulin polymerization by four most potent compounds 8g, 8j, 8n and 8o was also evaluated. The synthesis of the final targets was achieved adopting Staudinger reaction. Molecular modeling studies were performed to rationalize the biological results. � 2016, The Pharmaceutical Society of Korea.en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=19958&tip=sid&clean=0
dc.identifier.doihttps://doi.org/10.1007/s12272-016-0849-y
dc.identifier.doiPubMed ID 27747473
dc.identifier.issn2536269
dc.identifier.otherhttps://doi.org/10.1007/s12272-016-0849-y
dc.identifier.otherPubMed ID 27747473
dc.identifier.urihttps://t.ly/1VwlB
dc.language.isoEnglishen_US
dc.publisherPharmaceutical Society of Koreaen_US
dc.relation.ispartofseriesArchives of Pharmacal Research
dc.relation.ispartofseries40
dc.subjectOctober University for Modern Sciences and Arts
dc.subjectجامعة أكتوبر للعلوم الحديثة والآداب
dc.subjectUniversity of Modern Sciences and Arts
dc.subjectMSA University
dc.subjectAzetidin-2-oneen_US
dc.subjectCombretastatin A4en_US
dc.subjectCytotoxic activityen_US
dc.subjectTubulinen_US
dc.subject3 chloro 4 (4 chlorophenyl) 1 (4 methoxyphenyl) 3 methyl azetidin 2 oneen_US
dc.subject3 chloro 4 (furan 2 yl) 1 (4 methoxyphenyl)azetidin 2 oneen_US
dc.subject4 (2 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 oneen_US
dc.subject4 (2 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 phenylazetidin 2 oneen_US
dc.subject4 (2 bromophenyl) 3 chloro 1 (3,4,5 trimethoxyphenyl) 3 methylazetidin 2 oneen_US
dc.subject4 (2 bromophenyl) 3 chloro 1 (3,4,5 trimethoxyphenyl)azetidin 2 oneen_US
dc.subject4 (2 bromophenyl) 3 chloro 1 (4 methoxyphenyl) 3 methylazetidin 2 oneen_US
dc.subject4 (2 bromophenyl) 3 chloro 1 (4 methoxyphenyl)azetidin 2 oneen_US
dc.subject4 (3 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 oneen_US
dc.subject4 (3,4,5 trimethoxyphenyl) 1 (4 methoxyphenyl) 3 (2 thienyl)azetidin 2 oneen_US
dc.subject4 (4 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 oneen_US
dc.subject4 (4 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 phenylazetidin 2 oneen_US
dc.subject4 (4 bromophenyl) 3 chloro 1 (4 methoxyphenyl)azetidin 2 oneen_US
dc.subject4 (4 chlorophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 oneen_US
dc.subject4 (4 chlorophenyl) 1 (3,4,5 trimethoxyphenyl) 3 phenylazetidin 2 oneen_US
dc.subject4 (4 chlorophenyl) 1 (4 methoxyphenyl) 3 (2 theinyl)azetidin 2 oneen_US
dc.subjectazetidin 2 one derivativeen_US
dc.subjectazetidine derivativeen_US
dc.subjectcolchicineen_US
dc.subjectcombretastatin A4en_US
dc.subjectcytotoxic agenten_US
dc.subjectunclassified drugen_US
dc.subjectazetidineen_US
dc.subjectazetidine derivativeen_US
dc.subjectbibenzyl derivativeen_US
dc.subjectcombretastatinen_US
dc.subjectcytotoxinen_US
dc.subjectantiproliferative activityen_US
dc.subjectArticleen_US
dc.subjectcytotoxicityen_US
dc.subjectdrug binding siteen_US
dc.subjectdrug designen_US
dc.subjectdrug structureen_US
dc.subjectdrug synthesisen_US
dc.subjectHCT 116 cell lineen_US
dc.subjecthumanen_US
dc.subjecthuman cellen_US
dc.subjectin vitro studyen_US
dc.subjectisomerizationen_US
dc.subjectMCF-7 cell lineen_US
dc.subjectmicrotubule assemblyen_US
dc.subjectmolecular modelen_US
dc.subjectStaudinger reactionen_US
dc.subjectstructure activity relationen_US
dc.subjectcell survivalen_US
dc.subjectdrug effectsen_US
dc.subjectphysiologyen_US
dc.subjectsynthesisen_US
dc.subjectAzetidinesen_US
dc.subjectBibenzylsen_US
dc.subjectCell Survivalen_US
dc.subjectCytotoxinsen_US
dc.subjectHCT116 Cellsen_US
dc.subjectHumansen_US
dc.subjectMCF-7 Cellsen_US
dc.titleSynthesis and cytotoxic activity of certain trisubstituted azetidin-2-one derivatives as a cis-restricted combretastatin A-4 analoguesen_US
dc.typeArticleen_US
dcterms.isReferencedByAl-Tai, A.S., Hall, D.M., Mears, A.R., Nuclear magnetic resonance spectra of azomethines. Part I. Benzylideneanilines (1976) J Chem Soc, Perkin Trans, 2, pp. 133-136; Andreu, J.M., Perez-Ramirez, B., Gorbunoff, M.J., Ayala, D., Timasheff, S.N., Role of the colchicine ring A and its methoxy groups in the binding to tubulin and microtubule inhibition (1998) Biochemistry, 37, pp. 8356-8368. , COI: 1:CAS:528:DyaK1cXjtlWltLk%3D, PID: 9622487; Bandyopadhyay, D., Banik, B.K., Microwave-induced stereocontrol of ?-lactam formation with an N-benzylidene-9, 10-dihydrophenanthren-3-amine via Staudinger cycloaddition (2010) Helv Chim Acta, 93, pp. 298-301. , COI: 1:CAS:528:DC%2BC3cXitV2nsL0%3D; Bose, A.K., Banik, B.K., Manhas, M.S., Stereocontrol of ?-lactam formation using microwave irradiation (1995) Tetrahedron Lett, 36, pp. 213-216. , COI: 1:CAS:528:DyaK2MXjtlegt7c%3D; Banik, I., Becker, F.F., Banik, B.K., Stereoselective synthesis of ?-lactams with polyaromatic imines: entry to new and novel anticancer agents (2003) J Med Chem, 46, pp. 12-15. , COI: 1:CAS:528:DC%2BD38XptVagtr8%3D, PID: 12502355; Banik, B.K., Banik, I., Becker, F.F., Stereocontrolled synthesis of anticancer beta-lactams via the Staudinger reaction (2005) Bioorg Med Chem, 13, pp. 3611-3622. , COI: 1:CAS:528:DC%2BD2MXjvVKltrk%3D, PID: 15862989; Cragg, G.M., Newman, D.J., Plants as a source of anti-cancer agents (2005) J Ethnopharmacol, 100, pp. 72-79. , COI: 1:CAS:528:DC%2BD2MXmvVKnsLY%3D, PID: 16009521; Downing, K.H., Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics 1 (2000) Annu Rev Cell Dev Biol, 16, pp. 89-111. , COI: 1:CAS:528:DC%2BD3MXpvFOg, PID: 11031231; Dumontet, C., Jordan, M.A., Microtubule-binding agents: a dynamic field of cancer therapeutics (2010) Nat Rev Drug Discov, 9, pp. 790-803. , COI: 1:CAS:528:DC%2BC3cXht1akur%2FI, PID: 20885410; Dorleans, A., Gigant, B., Ravelli, R.B., Mailliet, P., Mikol, V., Knossow, M., Variations in the colchicine-binding domain provide insight into the structural switch of tubulin (2009) Proc Natl Acad Sci USA, 106, pp. 13775-13779. , COI: 1:CAS:528:DC%2BD1MXhtFWksLrO, PID: 19666559; Greene, T.F., Wang, S., Greene, L.M., Nathwani, S.M., Pollock, J.K., Malebari, A.M., Mccabe, T., Meegan, M.J., Synthesis and biochemical evaluation of 3-phenoxy-1,4-diarylazetidin-2-ones as tubulin-targeting antitumor agents (2016) J Med Chem, 59, pp. 90-113. , COI: 1:CAS:528:DC%2BC2MXhvFGnsr7L, PID: 26680364; Jordan, M., Mechanism of action of antitumor drugs that interact with microtubules and tubulin (2002) Curr Med Chem-Anti-Cancer Agents, 2, pp. 1-17. , COI: 1:CAS:528:DC%2BD38XislGmurg%3D; Klimczak, A.A., Kuropatwa, A., Lewkowski, J., Szemraj, J., Synthesis of new N-arylamino(2-furyl)methylphosphonic acid diesters, and in vitro evaluation of their cytotoxicity against esophageal cancer cells (2012) Med Chem Res, 22, pp. 852-860; Lippert, J.W., 3rd, Vascular disrupting agents (2007) Bioorg Med Chem, 15, pp. 605-615. , COI: 1:CAS:528:DC%2BD28XhtleisL7E, PID: 17070061; O�boyle, N.M., Carr, M., Greene, L.M., Bergin, O., Nathwani, S.M., Mccabe, T., Lloyd, D.G., Meegan, M.J., Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents (2010) J Med Chem, 53, pp. 8569-8584. , PID: 21080725; O�boyle, N.M., Carr, M., Greene, L.M., Keely, N.O., Knox, A.J., Mccabe, T., Lloyd, D.G., Meegan, M.J., Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe (2011) Eur J Med Chem, 46, pp. 4595-4607. , PID: 21840628; O�boyle, N.M., Greene, L.M., Bergin, O., Fichet, J.-B., Mccabe, T., Lloyd, D.G., Zisterer, D.M., Meegan, M.J., Synthesis, evaluation and structural studies of antiproliferative tubulin-targeting azetidin-2-ones (2011) Bioorg Med Chem, 19, pp. 2306-2325. , PID: 21397510; Ohsumi, K., Hatanaka, T., Fujita, K., Nakagawa, R., Fukuda, Y., Nihei, Y., Suga, Y., Tsuji, T., Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analogues (1998) Bioorg Med Chem Lett, 8, pp. 3153-3158. , COI: 1:CAS:528:DyaK1MXht1Kl, PID: 9873694; Skehan, P., Storeng, R., Scudiero, D., Monks, A., Mcmahon, J., Vistica, D., Warren, J.T., Boyd, M.R., New colorimetric cytotoxicity assay for anticancer-drug screening (1990) J Natl Cancer Inst, 82, pp. 1107-1112. , COI: 1:CAS:528:DyaK3cXltVylsL8%3D, PID: 2359136; Suresh, R., Kamalakkannan, D., Ranganathan, K., Arulkumaran, R., Sundararajan, R., Sakthinathan, S., Vijayakumar, S., Vanangamudi, G., Solvent-free synthesis, spectral correlations and antimicrobial activities of some aryl imines (2013) Spectrochimica Acta Part A, 101, pp. 239-248. , COI: 1:CAS:528:DC%2BC38XhslCjs7rE; Tozer, G.M., Prise, V.E., Wilson, J., Locke, R.J., Vojnovic, B., Stratford, M.R., Dennis, M.F., Chaplin, D.J., Combretastatin A-4 phosphate as a tumor vascular-targeting agent early effects in tumors and normal tissues (1999) Cancer Res, 59, pp. 1626-1634. , COI: 1:CAS:528:DyaK1MXisVWku7s%3D, PID: 10197639; Wang, L., Woods, K.W., Li, Q., Barr, K.J., Mccroskey, R.W., Hannick, S.M., Gherke, L., Marsh, K., Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation (2002) J Med Chem, 45, pp. 1697-1711. , COI: 1:CAS:528:DC%2BD38XhslOgtbc%3D, PID: 11931625; Wei, W., Ayad, N.G., Wan, Y., Zhang, G.J., Kirschner, M.W., Kaelin, W.G., Jr., Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex (2004) Nature, 428, pp. 194-198. , COI: 1:CAS:528:DC%2BD2cXhvFCls70%3D, PID: 15014503; West, C.M., Price, P., Combretastatin A4 phosphate (2004) Anticancer Drugs, 15, pp. 179-187. , COI: 1:CAS:528:DC%2BD2cXjslWqtL8%3D, PID: 15014350; Xu, J., Stereoselectivity in the synthesis of 2-azetidinones from ketenes and imines via the Staudinger reaction (2009) Arkivoc, 9, pp. 21-44
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Loading...
Thumbnail Image
Name:
Elmeligie2017_Article_SynthesisAndCytotoxicActivityO.pdf
Size:
1.03 MB
Format:
Adobe Portable Document Format
Description: